NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding NGM Biopharmaceuticals Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 121 | 2 | 119 | 0 |
| Shares | 45.2M | 39.6K | 47.1M | +1.87M (+4.1%) |
| Value | $951.2M | $831.0K | $833.5M | −$116.9M (−12.3%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Light Asset Management, LLC | 570,898 | $10.1M | 0.72% |
| Logos Global Management LP | 475,000 | $8.41M | 0.87% |
| Panagora Asset Management Inc | 67,066 | $1.19M | 0.01% |
| Wellington Management Group LLP | 28,185 | $500.0K | 0.00% |
| Putnam Investments LLC | 28,092 | $497.0K | 0.00% |
| First Trust Advisors LP | 23,900 | $423.0K | 0.00% |
| Algert Global LLC | 20,646 | $366.0K | 0.05% |
| ExodusPoint Capital Management, LP | 20,393 | $361.0K | 0.00% |
| Voloridge Investment Management, LLC | 14,559 | $258.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 13,700 | $243.0K | 0.00% |
| DnB Asset Management AS | 11,648 | $206.3K | 0.00% |
| DuPont Capital Management Corp | 9,670 | $171.0K | 0.01% |
| Canada Pension Plan Investment Board | 9,000 | $159.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 8,542 | $151.0K | 0.00% |
| Ensign Peak Advisors, Inc | 3,260 | $58.0K | 0.00% |
| Acadian Asset Management LLC | 1,740 | $30.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,003 | $18.0K | 0.00% |
| Massmutual Trust Co FSB | 34 | $1.00K | 0.00% |
| Covestor Ltd | 18 | $0 | 0.00% |
Sold out (19)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Candriam Luxembourg S.C.A. | 564,059 | $11.9M |
| Octagon Capital Advisors LP | 200,000 | $4.20M |
| Blackstone Group Inc. | 188,752 | $3.97M |
| Marshall Wace, LLP | 86,027 | $1.81M |
| ArrowMark Colorado Holdings LLC | 83,333 | $1.75M |
| Caption Management, LLC | 72,687 | $1.53M |
| Hamilton Lane Advisors LLC | 62,500 | $1.31M |
| Quilter Plc | 54,550 | $1.15M |
| Parkwood LLC | 50,000 | $1.05M |
| TD Asset Management Inc | 30,400 | $639.0K |
| Walleye Capital LLC | 22,368 | $470.0K |
| Principal Financial Group Inc | 14,628 | $307.0K |
| Handelsbanken Fonder AB | 10,000 | $210.0K |
| Steward Partners Investment Advisory, LLC | 2,000 | $42.0K |
| Cutler Group LP | 1,800 | $37.0K |
| Penserra Capital Management LLC | 1,765 | $37.0K |
| Federation des caisses Desjardins du Quebec | 714 | $15.0K |
| TCI Wealth Advisors, Inc. | 140 | $3.00K |
| Meridian Wealth Partners, LLC | 26 | $1.00K |
Not filed for Q4 2021 yet (2)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 39,503 | $830.0K |
| Berman Capital Advisors, LLC | 57 | $1.00K |